Cutaneous hyperpigmentation and vidarabine
Cirera, L.; Palou, J.; Estapé, J.
Medicina Clinica 81(15): 693
1983
ISSN/ISBN: 0025-7753 PMID: 6656419 Document Number: 218129
Document emailed within 1 workday
Related Documents
Ahuja, S.R.; Sharma, R.A. 2003: Reversible cutaneous hyperpigmentation in vitamin B12 deficiency Indian Pediatrics 40(2): 170-171Pui, J.C.; Meehan, S.; Moskovits, T. 2002: Capecitabine induced cutaneous hyperpigmentation: report of a case Journal of Drugs in Dermatology: Jdd 1(2): 202-205
Sciolla, J.P.; Guillot, B.; Barnéon, G.; Montoya, P.; Guilhou, J.J.; Meynadier, J. 1986: Association of a pediatric bullous eruption, cutaneous and muscular atrophy, hyperpigmentation and dysmorphism. A new entity? Annales de Dermatologie et de Venereologie 113(4): 317-327
Fabi, S.; Massaki, N.; Goldman, M.P. 2012: Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging Journal of Drugs in Dermatology: Jdd 11(8): 964-968
Kimura, T.; Doi, K. 1998: Efficacy of hydroquinone in the treatment of cutaneous hyperpigmentation in hairless descendants of Mexican hairless dogs (Xoloitzcuintli) Laboratory Animal Science 48(5): 469-475
E Silva, L.ís.P.C.T.; Luís, F.; Cabrera, H. 2008: Facial hyperpigmentation. amiodarone-induced hyperpigmentation American Family Physician 78(11): 1297-1298
Fabi, S.G.; Goldman, M.P. 2013: Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging Journal of Drugs in Dermatology: Jdd 12(3): S32-S37
Pavan-Langston, D. 1977: Use of vidarabine in Ophthalmology: a review Annals of Ophthalmology 9(7): 835-839
Chauplannaz, G.; Trepo, C.; Bady, B.; Brunon, A.M. 1985: Neurotoxicity of vidarabine in chronic active hepatitis Presse Medicale 14(20): 1154
Genée, E.; Maith, J. 1987: Comparison of the effectiveness of acyclovir and vidarabine in superficial herpes keratitis Klinische Monatsblatter für Augenheilkunde 191(1): 30-32
Ouzan, D. 1992: Vidarabine phosphate in the treatment of active chronic hepatitis B. a confirmed hope La Revue du Praticien 42(11): 1383-1386
Whitley, R.J.; Yeager, A.; Kartus, P.; Bryson, Y.; Connor, J.D.; Alford, C.A.; Nahmias, A.; Soong, S.J. 1983: Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy Pediatrics 72(6): 778-785
Shepp, D.H.; Dandliker, P.S.; Meyers, J.D. 1988: Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine American Journal of Medicine 85(2a): 96-98
Kostas, T.; Carty, M.J.; Lin, J.Y.; Granter, S.R.; Osman, N. 2012: Hyperpigmentation and atrophy Journal of Family Practice 61(10): 617-619
Szekeres, E.; Korom, I.; Zombai, E. 1990: Hyperpigmentation of the face Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 41(3): 164-167
Kumar, L.; Kochipillai, V. 1990: Mitoxantrone induced hyperpigmentation New Zealand Medical Journal 103(883): 55
2014: Interferon alfa: hyperpigmentation Prescrire international 23(154): 268
Kalamkarian, A.A.; ShadyevHK 1984: Paraneoplastic hyperpigmentation of the skin Vestnik Dermatologii i Venerologii 6: 4-7
Santra, G.; Paul, R.; Ghosh, S.K.; Chakraborty, D.; Das, S.; Pradhan, S.; Das, A. 2014: Generalised hyperpigmentation in vitamin B12 deficiency Journal of the Association of Physicians of India 62(8): 714-716
Skogh, M.; Moi, H. 1978: Nevus-spilus-like hyperpigmentation in psoriasis Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 29(11): 607